Society of Hematologic Oncology

Free SOHO Membership: www.sohoonline.org

 

Acute Lymphoblastic Leukemia
14:35

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Moving Beyond Single Antigen CAR-T Targeting in ALL: Current Status and Limitations, Advances in Combinatorial Targeting Strategies, and Future Directions

FEATURING Nirali Shah
  • 10 views
  • October 17, 2019
12:05

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Is HCT Still Needed in the Era of Targeted Cellular Therapies for Acute Lymphoblastic Leukemia?

FEATURING Partow Kebriaei
  • 44 views
  • October 17, 2019
14:09

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Is HCT Still Necessary in the Era of Targeted Cellular Therapy for ALL? Vision - Less and Less HCT

FEATURING Michael Pulsipher
  • 9 views
  • October 17, 2019
14:38

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Combining Genotype Profiling with MRD for More Accurate Prognostication in ALL

FEATURING Jack Bartram
  • 6 views
  • October 17, 2019
15:09

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Ph+ ALL: How Can We Optimize Treatment for All Patients Through Better Molecular Stratification and Better Therapeutic Management (TKIs +/- Chemo, CAR-T)?

FEATURING Sabina Chiaretti
  • 6 views
  • October 17, 2019
04:11

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Management of Adult ALL: Which Chemo Intensity, Further Progress With Pediatric-Inspired Protocol, Integration of Targeted Therapy in Frontline and Maintenance?

FEATURING Dieter Hoelzer
  • 14 views
  • October 17, 2019
12:37

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Novel Therapies in Older Patients with Ph- B-Cell ALL: Older ALL, Poor Outcome, HCVD-Ino-Blina Safe, but High Death in CR, Combos and Targeted Therapies Moving Forward

FEATURING Elias Jabbour
  • 26 views
  • November 18, 2019
14:53

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

The Challenge of Improving Outcomes for ETP ALL and Relapsed Disease: Recognition of High Risk Subtypes May Allow for Intensification of Frontline Therapy

FEATURING Bijal Shah
  • 11 views
  • November 18, 2019
09:16

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Duplex Sequencing Identifies Low Level ABL1 Kinase Domain Mutations in Untreated Philadelphia Chromosome-Positive ALL

FEATURING Nicholas Short
  • 7 views
  • November 18, 2019
07:55

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

More or Less? Impact of Dose Number on Outcomes of Patients w/ ALL Treated with Inotuzumab Ozogamicin

FEATURING Elias Jabbour
  • 36 views
  • November 18, 2019